AlloVir, Inc. (ALVR)
NASDAQ: ALVR · IEX Real-Time Price · USD
0.780
+0.019 (2.43%)
Mar 28, 2024, 9:56 AM EDT - Market open

AlloVir Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
00000.171.14
Revenue Growth (YoY)
-----85.46%-
Gross Profit
00000.171.14
Selling, General & Admin
48.2652.3349.0821.6510.623.03
Research & Development
133.07118.87120.7449.6616.251.7
Other Operating Expenses
18.5700000
Operating Expenses
199.9171.2169.8271.3126.874.73
Operating Income
-199.9-171.2-169.82-71.31-26.7-3.6
Other Expense / Income
-9.36-2.231.14-1.53-2.86-1.17
Pretax Income
-190.54-168.98-170.96-69.78-23.84-2.43
Income Tax
-0.13-0.271.01000
Net Income
-190.42-168.71-171.96-69.78-23.84-2.43
Preferred Dividends
000005.73
Net Income Common
-190.42-168.71-171.96-69.78-23.84-8.16
Shares Outstanding (Basic)
10477632710
Shares Outstanding (Diluted)
10477632710
Shares Change
35.75%22.10%133.41%1991.66%322.11%-
EPS (Basic)
-1.83-2.20-2.74-2.59-18.54-25.07
EPS (Diluted)
-1.83-2.20-2.74-2.59-18.54-25.07
Free Cash Flow
-124.45-142.05-106.35-61.05-20.491.94
Free Cash Flow Per Share
-1.20-1.85-1.69-2.27-15.946.38
Gross Margin
----100.00%100.00%
Operating Margin
-----16182.42%-316.83%
Profit Margin
-----14447.88%-718.59%
Free Cash Flow Margin
-----12420.61%171.19%
EBITDA
-182.25-166.41-169.84-69.71-23.82-2.43
EBITDA Margin
-----14436.36%-214.10%
Depreciation & Amortization
8.292.571.120.070.020
EBIT
-190.54-168.98-170.96-69.78-23.84-2.43
EBIT Margin
-----14447.88%-214.10%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).